Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Almost 13 Million Americans Per Year Skip Meds Due to CostAssistance Dogs Bring Big Boost to Deaf PeopleCDC to Toughen COVID Testing for International TravelersOld Spice, Secret Antiperspirants Recalled Due to BenzeneClinical Trials Are Becoming More Diverse, But There's Still Work To DoRural Hospitals' ERs Just as Effective as Urban Ones: StudyKraft Recalls Powdered Drinks Over Metal, Glass ConcernsVials Found in Lab Contained Vaccine, not Smallpox Virus: CDCAdvances in Care, Impact of COVID Highlights of Latest Cardiologists' MeetingAcross America, Black People Have Worse Health OutcomesVials With Smallpox Labels Found at Vaccine Lab in Pennsylvania: CDCWhite House to Spend Billions to Boost COVID Vaccine SupplyAHA News: Health Class May Influence Heart Risk in South AsiansPfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor CountriesFederal Court Backs Stay on COVID Vaccine Mandate for Large BusinessesMore Than 2 Million COVID Home Test Kits Recalled Due to False Positive ResultsIn Canada, Ban on Menthol Cigarettes Had More Smokers QuittingOklahoma Supreme Courts Overturns $465 Million J & J Opioid RulingPandemic Puts 'Outdated' Infection Control Practices Under ScrutinyMillions of Tons of COVID Masks, Gloves Will End Up in OceansSales of Unproven, Unapproved Stem Cell Therapies Are BoomingCourt Temporarily Blocks Biden’s Vaccine Mandate for Big BusinessesU.S. Reopens Borders to Vaccinated Foreign TravelersIt's Time to Replace Your Smoke Alarm BatteriesAHA News: How Doctors Can Help Their Patients Make Heart-Healthy Lifestyle ChangesWhite House Sets Jan. 4 Deadline for Large, Private U.S. Companies to Mandate VaccinesHepatitis B Shots Advised for All U.S. Adults Under 60Supply Chain Issues Bring Shortages of Drugs, Devices to U.S. HospitalsMedicare Could Negotiate Drug Prices Under Democrat ProposalWe've Been Here Before: How Polio Vaccine Rollout Saved Millions of Young LivesAlmost 1 in 3 U.S. Seniors Now Sees at Least 5 Doctors Per YearLanguage Can Make the Difference Between Home, Hospital Care: StudyAttorneys General Warn About Pot Products That Look Like Halloween TreatsCDC Lowers Threshold for Lead Poisoning in Youngest KidsStronger Breast Implant Safety Measures Announced by FDAWalmart Recalls Room Spray for Rare Bacteria That Sickened 4, Killing 2U.S. Gun Violence Rates Jumped 30% During PandemicMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyU.S. Has Shared 200 Million Shots With Other CountriesLittle Change Seen in Americans' Use of Mental Health Services During PandemicWomen Doctors Face Higher Levels of Harassment, Frustration: SurveyEPA Plans New Strategy Against PFAS 'Forever Chemicals'State Spending on Poverty Really Pays Off for Kids: StudyState Lotteries Didn't Help Boost Vaccination RatesVaccinated Foreign Travelers Can Enter United States Beginning Nov. 8Despite Pressures of Pandemic, U.S. Nursing School Enrollment ClimbsBiden Administration to Invest $100 Million to Ease Health Worker ShortageFDA Warns Against Using At-Home Dermal Filler 'Pens'Death Threats, Trolling Common for Scientists Who Speak to Media About COVID'Extreme Heat' Days Have Tripled Since 1980s, and More Are Coming
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Hepatitis B Shots Advised for All U.S. Adults Under 60

HealthDay News
by Robert Preidt
Updated: Nov 4th 2021

new article illustration

THURSDAY, Nov. 4, 2021 (HealthDay News) -- All U.S. adults younger than 60 should be vaccinated against hepatitis B, the Advisory Committee on Immunization Practices recommended Wednesday.

Until now, the shots were recommended only for certain groups of adults, including prisoners, health care workers, international travelers, people with diabetes and certain other conditions, and those who inject drugs or who have multiple sexual partners, the Associated Press reported.

Hepatitis B vaccinations became standard for U.S. children in 1991, so most adults younger than 30 are already protected.

The government advisory committee's unanimous decision -- which still requires the approval of the U.S. Centers for Disease Control and Prevention -- comes as progress against the liver-damaging disease stalls.

It's not clear when CDC Director Dr. Rochelle Walensky will make a decision on the committee's recommendation.

If she gives the OK, tens of millions of adults between the ages of 30 and 59 would be advised to get the shots against the liver-damaging disease, the AP reported.

The shots are given in either two or three doses, spaced a month or more apart. CDC data suggests that only about one-third of people with diabetes and chronic liver conditions have been vaccinated, and just two-thirds of eligible health care workers, the AP reported. Overall, about 30% of all adults are vaccinated.

Roughly 1.9 million Americans are living with hepatitis B infections, though many may not experience liver damage for many years. The U.S. government has set a goal of eliminating viral hepatitis by 2030.

About 20,000 new hepatitis B infections occur each year in the United States, according to health officials. The rate has been generally stable, but has been rising among adults in their 40s and 50s. The virus is spread through contact with blood or other bodily fluids, and many recent cases have been linked to the opioid epidemic, the AP said.

"We're losing ground. We cannot eliminate hepatitis B in the U.S. without a new approach," the CDC's Dr. Mark Weng told the AP.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on hepatitis B.

SOURCE: Associated Press




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net